HAPN
Happen, Inc. Common Stock
HAPN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over HAPN overall, supported by stronger modeled upside and lower modeled downside.
HAPN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
HAPN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HAPN.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
HAPN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.1x | $15.27 | — |
| Current | 8.5x | $15.27 | — |
| Cheap | 12x | $21.59 | +41% |
| Fair | 23x | $42.16 | +176% |
| Expensive | 29x | $52.47 | +244% |
Historical ranges are pointers, not guarantees.
HAPN has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
HAPN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HAPN, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
HAPN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.16 | +20% |
| Q3 2026 | $1.80 | +105% |
| Q2 2026 | $1.67 | +161% |
| Q1 2026 | $1.50 | +241% |
| Q4 2025 | $1.16 | +158% |
| Q3 2025 | $0.88 | +91% |
| Q2 2025 | $0.64 | +68% |
| Q1 2025 | $0.44 | +29% |
| Q4 2024 | $0.45 | +25% |
HAPN has the edge over MS on earnings, with stronger typical year-over-year growth.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
HAPN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $263.2M | -1.2% |
| Q2 2026 | $262.9M | +5.8% |
| Q1 2026 | $252.3M | +16% |
| Q4 2025 | $266.5M | +23% |
| Q3 2025 | $266.2M | +32% |
| Q2 2025 | $248.4M | +33% |
| Q1 2025 | $217.7M | +20% |
| Q4 2024 | $217.2M | +17% |
HAPN's revenue is growing: $263M last quarter, down 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +7.7 points |
| Q2 2026 | 29% | +7.1 points |
| Q1 2026 | 27% | +20 points |
| Q4 2025 | 19% | +14 points |
| Q3 2025 | 22% | +13 points |
| Q2 2025 | 22% | +11 points |
| Q1 2025 | 7.2% | -1.9 points |
| Q4 2024 | 5.1% | -2.3 points |
HAPN's operating margin was 29% last quarter, up 7.7 points from the same quarter a year ago, near the top of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over HAPN on profitability, with a higher operating margin.
HAPN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$709.7M | +$82.1M |
| Q2 2026 | -$600.9M | +$202.9M |
| Q1 2026 | -$644.8M | -$292.5M |
| Q4 2025 | -$919.3M | -$716.8M |
| Q3 2025 | -$791.8M | -$109.6M |
| Q2 2025 | -$803.8M | +$141.5M |
| Q1 2025 | -$352.3M | +$506M |
| Q4 2024 | -$202.6M | +$623.5M |
HAPN has the edge over MS on cash flow, with more consistent year-over-year improvement.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
HAPN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +308K shares |
| 1 year | -0.5% | -606K shares |
| 3 years | +7.8% | +8.5M shares |
HAPN has 118M diluted shares, down 0.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $8.2M |
| Q2 2026 | $7.8M |
| Q1 2026 | $12.6M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over HAPN on shareholder dilution, with a more favorable share count trend.
HAPN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | 2.5x | Moderate |
| Q4 2023 | -0.1x | Net Cash |
HAPN has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like HAPN.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
HAPN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.2 | Neutral |
HAPN's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
HAPN PE vs Financial Services Sector
| Metric | HAPN | Sector median | Relative |
|---|---|---|---|
| PE | 8.5x | 13x | 35% below |
| PE % | 1 | 63 | 62 pts below |
HAPN has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
HAPN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.1 | 1% above |
| 20 week MA | $17.2 | 11% below |
| 50 week MA | $17.2 | 11% below |
| 100 week MA | $15.5 | 1.7% below |
| 200 week MA | $12.3 | 24% above |
HAPN's trend is mixed: it's above two of its five weekly moving averages, and 24% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over HAPN on trend strength, trading above more of its moving averages.
HAPN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.5 | $8.82 | -30% |
| 2021 | $8.82 | $25.8 | +192% |
| 2022 | $25.8 | $8.67 | -66% |
| 2023 | $8.67 | $8.74 | +0.8% |
| 2024 | $8.74 | $16.7 | +91% |
| 2025 | $16.7 | $19.6 | +18% |
| 2026 YTD | $19.6 | $15.3 | -22% |
HAPN's yearly returns have swung widely, from +192% in 2021 to −66% in 2022. It's down 22% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over HAPN on returns for 2026, with the stronger performance.